COX-2 as a potential biomarker and therapeutic target in melanoma

COX-2 as a potential biomarker and therapeutic target in melanoma

With a constantly increasing incidence, cutaneous melanoma has raised the need for a better understanding of its complex microenvironment that may further guide therapeutic options. Melanoma is a model tumor in immuno-oncology. Inflammation represents an important hallmark of cancer capable of induc...

Full description

Bibliographic Details
Main Authors: Diana Valentina Tudor, Ioana Bâldea, Mihai Lupu, Teodor Kacso, Eniko Kutasi, Andreea Hopârtean, Roland Stretea, Adriana Gabriela Filip
Format: Article
Language:English
Published: China Anti-Cancer Association 2020-02-01
Series:Cancer Biology & Medicine
Subjects:
melanoma
inflammation
cox-2
cox-2 inhibitors
celecoxib
Online Access:http://www.cancerbiomed.org/index.php/cocr/article/view/1562

Internet

http://www.cancerbiomed.org/index.php/cocr/article/view/1562

Similar Items